Lung Cancer Surgery Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global Lung Cancer Surgery Market estimated at US$25.5 Billion in the year 2020, is projected to reach a revised size of US$37.4 Billion by 2027, growing at a CAGR of 5% over the period 2021-2027.

Lung cancer surgery is used to remove the tumor along with some surrounding lung tissue. Surgery depends on the type, location, and stage of lung cancer, and other medical conditions. Surgery includes early-stage non-small cell lung cancer and carcinoid tumors. There are four types of lung surgery: pulmonary resection, lobectomy, segmentectomy or wedge resection, and sleeve resection.

Market Segments

By Surgical Devices

•  Surgical Instruments
• Hand Instruments
• Monitoring and Visualizing Systems
• Endosurgical Equipment

By Surgical Procedures

• Thoracotomy
• Lobectomy
• Sleeve Resection
• Segmentectomy
• Pneumonectomy
• Minimally Invasive Surgeries

Key Players

• KARL STORZ GmbH
• Covidien PLC
• Accuray Inc
• Ackermann Instrumente GmbH
• Intuitive Surgical Inc.
• Olympus Corporation
• Trokamed GmbH
• Teleflex Inc.

Scope of the Report

The research study analyzes the global Lung Cancer Surgery industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Lung Cancer Surgery Market Report

1. What was the Lung Cancer Surgery Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Lung Cancer Surgery Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Lung Cancer Surgery Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.